China Universal Asset Management Company’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

China Universal Asset Management Company’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,594	Closed	-$18.6K	–	532
2024 Q3	$18.6K	Buy	10,594 +4,139	+64%	+$5.78K	﹤0.01%	406
2024 Q2	$7.55K	Sell	6,455 -4,003	-38%	-$10K	﹤0.01%	402
2024 Q1	$94.5K	Buy	10,458 +4,151	+66%	+$40.4K	0.01%	379
2023 Q4	$68.6K	Buy	6,307 +5,003	+384%	+$37.5K	0.01%	331
2023 Q3	$10.5K	Buy	1,304 +642	+97%	+$5.34K	﹤0.01%	342
2023 Q2	$7.19K	Sell	662 -10	-1%	-$86	﹤0.01%	338
2023 Q1	$4.64K	Buy	672 +187	+39%	+$1.17K	﹤0.01%	372
2022 Q4	$1.93K	Buy	485 +136	+39%	+$669	﹤0.01%	375
2022 Q3	$2K	Buy	+349	New	+$2.15K	﹤0.01%	372

Other funds holding MRNS

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

China Universal Asset Management Company's MRNS Position: Q4 2024 in Review

China Universal Asset Management Company sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 10,594 shares — an estimated $18.6K sold.

China Universal Asset Management Company first reported a position in MRNS in Q3 2022 and held it in 9 quarters. The position peaked at $94.5K in Q1 2024. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

China Universal Asset Management Company reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
China Universal Asset Management Company sold 10,594 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $18.6K.
China Universal Asset Management Company first reported a position in Marinus Pharmaceuticals, Inc in Q3 2022 and held it in 9 quarters.
China Universal Asset Management Company's Marinus Pharmaceuticals, Inc position peaked at $94.5K in Q1 2024.
53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.